BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38197653)

  • 1. Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection.
    Horta AL; Gigley J; Boutet M; Lavau G; Weiss LM; Huang H
    J Immunol; 2024 Feb; 212(4):617-631. PubMed ID: 38197653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Effective Immunity against Trypanosoma cruzi.
    Williams T; Guerrero-Ros I; Ma Y; Matos Dos Santos F; Scherer PE; Gordillo R; Horta A; Macian F; Weiss LM; Huang H
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31907197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible suicide vector systems for Trypanosoma cruzi.
    Ma Y; Weiss LM; Huang H
    Microbes Infect; 2015 Jun; 17(6):440-50. PubMed ID: 25899945
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Driving of Immune Response by Th1 Adjuvants in Immunization of Mice with Trypanosoma cruzi marinkellei Elicits a Controversial Infection Control.
    Nascentes GA; Hernández CG; Rabelo RA; Coelho RF; Morais FR; Marques T; Batista LR; Meira WS; Oliveira CJ; Lages Silva E; Ramírez LE
    Vector Borne Zoonotic Dis; 2016 May; 16(5):317-25. PubMed ID: 26959861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
    Serna C; Lara JA; Rodrigues SP; Marques AF; Almeida IC; Maldonado RA
    Vaccine; 2014 Jun; 32(28):3525-32. PubMed ID: 24793944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
    Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
    Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
    [No Abstract]   [Full Text] [Related]  

  • 10. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
    Chowdhury IH; Lokugamage N; Garg NJ
    Front Immunol; 2020; 11():595039. PubMed ID: 33414785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.
    Miyahira Y; Katae M; Takeda K; Yagita H; Okumura K; Kobayashi S; Takeuchi T; Kamiyama T; Fukuchi Y; Aoki T
    Infect Immun; 2003 Mar; 71(3):1234-41. PubMed ID: 12595437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
    Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection.
    Fralish BH; Tarleton RL
    Vaccine; 2003 Jun; 21(21-22):3070-80. PubMed ID: 12798651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain.
    Vasconcelos JR; Boscardin SB; Hiyane MI; Kinoshita SS; Fujimura AE; Rodrigues MM
    Immunol Cell Biol; 2003 Apr; 81(2):121-9. PubMed ID: 12631235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
    Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
    Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
    Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
    PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.